Edition:
India

Adaptimmune Reports Q1 Loss Per Share $0.04


Monday, 6 May 2019 

May 6 (Reuters) - Adaptimmune Therapeutics PLC ::ADAPTIMMUNE REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.04.Q1 EARNINGS PER SHARE ESTIMATE $-0.31 -- REFINITIV IBES DATA.FINANCIAL GUIDANCE UPDATED.ADAPTIMMUNE THERAPEUTICS - BELIEVES EXISTING CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES WILL FUND COMPANY'S CURRENT OPERATIONS INTO Q3 OF 2020.ADAPTIMMUNE THERAPEUTICS - REVENUE FOR THREE-MONTH PERIOD ENDED MARCH 31, 2019 WAS NIL, COMPARED TO $8.2 MILLION FOR SAME PERIOD IN 2018.AS OF MARCH 31, CO HAD CASH AND CASH EQUIVALENTS OF $49.9 MILLION AND TOTAL LIQUIDITY OF $168.2 MILLION. 

Company Quote

3.65
0.38 +11.62%
1:30am IST